From: Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction
ADR
n
%*
Hypotension
285
36.0
Arrhythmias
281
35.5
Chills
212
26.8
Tremors
197
24.9
Vomiting
187
23.6
Nauseas
103
13.0
Allergy
47
5.9
Bleeding
43
5.4
Fever
41
5.2
Lumbar pain
10
1.3
Sweating
9
1.1
Muscular cramp
5
0.6
Others
76
9.6